Precision Medicine For Your Practice: Prenatal Cell-free DNA Screening
Webcast
OVERVIEW
Precision Medicine For Your Practice: Prenatal Cell-free DNA Screening is organized by American Medical Association (AMA) and will be held during Aug 30, 2016 - Aug 30, 2019.
The target audience for this medical event is practicing physicians who provide prenatal care. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Description :
Precision Medicine For Your Practice is a series of short (approximately 30 min), online modules covering specific topics in genomics and precision medicine. In this module, Prenatal Cell-free DNA Screening, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care. Prenatal providers and patients have more options than ever for screening for Down syndrome and other chromosome conditions, including cell-free DNA screening. While cell-free DNA screening, also called noninvasive prenatal testing, is a powerful tool, it is not the best test for all pregnant women. Learn about specific benefits, limitations, and challenges in results interpretation and counseling using the five parts of this module: overview information via an animated video; practice cases to facilitate learning-by-doing; and "dig deeper," logistics, and additional resources for more detail.
Objectives :
At the end of this activity, physicians should be able to:
• Determine whether expanded carrier screening is appropriate for the patient.
• Interpret results of carrier screening in the context of the patient characteristics.
Additional details will be posted as soon as they are available.
The target audience for this medical event is practicing physicians who provide prenatal care. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Description :
Precision Medicine For Your Practice is a series of short (approximately 30 min), online modules covering specific topics in genomics and precision medicine. In this module, Prenatal Cell-free DNA Screening, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care. Prenatal providers and patients have more options than ever for screening for Down syndrome and other chromosome conditions, including cell-free DNA screening. While cell-free DNA screening, also called noninvasive prenatal testing, is a powerful tool, it is not the best test for all pregnant women. Learn about specific benefits, limitations, and challenges in results interpretation and counseling using the five parts of this module: overview information via an animated video; practice cases to facilitate learning-by-doing; and "dig deeper," logistics, and additional resources for more detail.
Objectives :
At the end of this activity, physicians should be able to:
• Determine whether expanded carrier screening is appropriate for the patient.
• Interpret results of carrier screening in the context of the patient characteristics.
Additional details will be posted as soon as they are available.
SPECIALITIES
GeneticsObstetrics and GynecologyMidwiferyRELATED ONLINE COURSES
Quick Links